Week 7- DM/ Thyroid Flashcards
What drug is in the biguanide class
metformin (glucophage)
what MoA is metformin
Decrease hepatic glucose production by decreasing gluconeogenesis
Causes an increase in peripheral glucose uptake + utilization (sensitivity)
(Reduces glucose uptake in GI tract)
Does not stimulate insulin release
what are the common uses for metformin
first line DM medication, initial monotherapy for adults/kids
black box warning of metformin
BOX WARNING: Rare but life-threatening lactic acidosis, hypothermia, hypotension, bradycardia death (50% fatality)
side effects of metformin
gas, diarrhea, weight loss, DOES NOT DIRECTLY C/ HYPOGLYCEMIA.. but it can still happen
contraindications of metformin
advanced renal disease, metabolic acidosis, monitor renal function
drug interactions of metformin
avoid iodine-based contrast (hold 48 hrs before/after imaging), watch drugs that use renal excretion too
what drugs are in the DPP-4 inhibitor class
linagliptin, saxagliptin, sitagliptin
MoA of gliptans
Acts on incretin system- stimulate insulin secretion from pancreatic beta cells
Slow gastric emptying by prolonging action of GLP-1 hormones
common uses of gliptins
DM-2
OK monotherapy—
Typically adjunct
Overweight & DM-2
side effects of gliptins
Arthralgia
Pancreatitis
Skin autoimmune issues
Rhabdo
Heart failure
drug interactions of gliptins
ACEI, DM drugs, Quinilones, Protease inhibitors: Higher risk hypoglycemia
Dig
GLP-1 receptor agonist drugs
dulaglutitide, exenatide, liraglutide
MoA of GLP-1 “glutides”
Acts on incretin system- stimulate insulin secretion from pancreatic beta cells and decrease glucagon release from alpha cells
(increases insulin secretion, lowers glucose levels, delays gastric emptying, induces weight loss)
GLP-1 Receptor Agonists
Combo w/ other meds for poorly controlled type 2 DM
& Obesity + CVD
NOT FOR DM-1
CI for all GLP 1 Receptor Agonists
GI disease (UC, crohn’s, gastroparesis, pancreatitis
also not recommends for people with renal impairment
side effects of GLP-1 receptor agonists
GI distubrances, pancreatic duct metaplasia, pancreatitis, thyroid tumors
black box warning GLP 1 Receptor
Agonists
thyroid C-Cell tumors and hyperplasia BOX WARNING
which GLP 1 agonists has the most nausea
exenatide
Dulaglutide can increase or decrease CV events
Decrease CV events
DDI of GLP 1
Most drug interactions tied to delayed gastric emptying & dual therapy hypoglycemia
ASA, salicylates, fibrates, MAOIs, sulfonamides, ARBs and ACEIs, beta blockers, contraceptives, Dig
which GLP 1 has the highest propensity for increased INR with warfarin
exenatide
which drugs are SGLT2 inhibitors
canaglifozin, dapagliflozin, empaglifozin “flozins”
what is the mechanism of action of flozins/ SGLT2 inhibitors
Inhibits SGLT2: blocks reabsorption of glucose in the kidneys & promotes excretion of glucose
No effect on natural insulin secretion